Stay updated with breaking news from Johnl Sapp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An analysis of the RAFT trial showed patients with heart failure treated with CRT-D experienced continued survival benefits during a median of nearly 14 years of follow-up.
Ablation bested intensified antiarrhythmics in a new analysis. Such patients don't need to be VT-free to reap benefits.
Cardiac resynchronization extended survival during 5 extra years of follow-up of the RAFT study, which compared CRT-D with ICD defibrillation alone.
New analysis of a 2015 study shows a link between intensive BP control and risk for new LV conduction disease, suggesting the conduction system could be seen 'as something we should protect.'